Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'mutant idh1 inhibitor'

Search results for: 'mutant idh1 inhibitor'

Items 41-50 of 65

Page
per page
  1. Letrozole
    A1307 Letrozole
    Target: Aromatases
    Summary: Non-steroidal aromatase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.265 mg/mL
  2. PD98059
    A1663 PD98059
     9 Citation
    Target: MEK
    Summary: MEK inhibitor,selective and reversible
      insoluble in EtOH; insoluble in H2O; ≥40.23 mg/mL
  3. PR-619
    A8212 PR-619
    Target: Deubiquitinating enzymes (DUBs)
    Summary: Deubiquitylating enzymes (DBUs) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
  4. Trichostatin A (TSA)
    A8183 Trichostatin A (TSA)
     13 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; ≥15.12 mg/mL
  5. Ro 3306
    A8885 Ro 3306
     4 Citation
    Target: Cyclin-Dependent Kinases
    Summary: An ATP-competitive, potent CDK1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL
  6. Entacapone
    A4168 Entacapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
  7. MK-0752
    A4006 MK-0752
     1 Citation
    Summary: γ-secretase inhibitor
      ≥22.15 mg/mL
  8. KU-60019
    A8336 KU-60019
     2 Citation
    Target: ATM/ATR
    Summary: ATM kinase inhibitor,potent and selective
      ≥27.4 mg/mL
  9. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  10. AZ505
    B1255 AZ505
    Target: SMYD2
    Summary: SMYD2 inhibitor,potent and selective
      Soluble in DMSO

Items 41-50 of 65

Page
per page
Shop By
Now Shopping by
  1. Reversibility Reversible Remove This Item
Clear All
Shopping Options
Specificity
  1. Selective 54item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 2item
  3. Proteasome 3item
  4. Cathepsins 4item
  5. Histone Deacetylases (HDACs) 2item
  6. Akt 1 item
  7. PI3K 2item
  8. CXCR 1 item
  9. Raf 1 item
  10. Aurora Kinases 2item
  11. mTOR 1 item
  12. MMP 1 item
  13. Myosin II ATPases 1 item
  14. Factor Xa 1 item
  15. PLK 1 item
  16. Chk 1 item
  17. JNK 1 item
  18. MEK 1 item
  19. Deubiquitinating enzymes (DUBs) 1 item
  20. Src 1 item
  21. NMDA Receptors 1 item
  22. Microtubules/Tubulins 2item
  23. EGFR 2item
  24. FAK 3item
  25. JAK 2item
  26. Syk 1 item
  27. AMPK 1 item
  28. S-nitrosoglutathione reductase 1 item
  29. CFTR 1 item
  30. thrombin 1 item
  31. ErbB 2item
  32. Actin 1 item
  33. ERK 1 item
  34. PKC 1 item
  35. Calpains 1 item
  36. SMYD2 1 item
  37. RAD51 1 item
  38. Trypsins 1 item
  39. Pyk2 3item
  40. Insulin and Insulin-like Receptors 1 item
  41. ALK 1 item
  42. GTPases 1 item
  43. CETP 1 item
  44. PKA 1 item
  45. Myosin light chain kinases (MLCKs) 1 item
  46. MK2 1 item
  47. ATM/ATR 1 item
  48. AChE 1 item
  49. ZAP-70 1 item
  50. Catechol O-Methyltransferase (COMT) 1 item
  51. DPP-4 1 item
  52. Dipeptidyl-peptidase II 1 item
  53. P97 ATPase 1 item
  54. Aromatases 1 item
  55. UCH 1 item
  56. MST 1 item
  57. ATM 1 item
Reported Experiments
  1. Animal Experiments 54item
  2. Cell Experiments 34item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 1 item
  3. Breast Cancer 9item
  4. Cancer 28item
  5. Colon Cancer 3item
  6. Colorectal Cancer 2item
  7. Diabetes 1 item
  8. Glioblastoma 1 item
  9. Glioma 1 item
  10. Hepatocellular Carcinoma 2item
  11. Hypercholesterolemia 1 item
  12. Inflammatory Diseases 2item
  13. Leukemia 2item
  14. Lung Cancer 2item
  15. Lymphoma 1 item
  16. Mantle Cell Lymphoma 1 item
  17. Multiple Myeloma 1 item
  18. Pancreatic Cancer 4item
  19. Psoriasis 1 item
  20. Renal Cancer 1 item
  21. Rheumatoid Arthritis 1 item